Answers are grounded in this paper and cite their sources.
A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.
No takes yet. Share an insight, caveat, or question.
Weyer et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: